21 May 2009
Logistic methods of organ’s cold ischaemia time reduction in simultaneous pancreas and kidney transplantation
S Sekta, J Ziaja, R Król, L CierpkaAnn Transplant 2009; 14(1): 45-45 :: ID: 880363
Abstract
Background: Cold ischemia time (CIT) of pancreatic graft is an important factor that influences the results of simultaneous pancreas and kidney transplantation (SPK). The aim of the study is to present logistic methods reducing CIT of pancreatic graft during SPK.
Material/Methods: 32 SPK performed from 2004 to 2008 were analyzed. Lymph nodes (LN) for cross-matching were procured immediately after donor brain death diagnosis. In 12 cases cross-match was done locally (in Katowice) and in 20 - centrally (in the capital of Poland). During LN transport and cross-matching preliminary identification, selection and preparation of 2-3 potential recipients was completed. Finally, selected recipient was sent out to the transplant centre and the transplant team sent out to organ retrieval hospital as soon as the results of the cross-match were obtained.
Results: Mean duration of LN transport and cross-matching was 10 h (identical for local and central typing). Mean duration of recipient's transport to the transplant centre was 2.3 h (0.5 h for local recipients and 3.3h for re-mote recipients). It did not exceed the duration of transplant team's transport and harvesting operation which was 4.7 h (4.3 h for local and 6.8 h for remote retrieval). Mean pancreas CIT was 7.5 h and kidney - 9.1h. 12.5% of patients lost pancreatic graft due to thrombosis. There was no primary kidney graft non-function in the analyzed group.
Conclusions: Early donor lymph nodes procurement for cross-matching as well as early potential recipient's identification, selection and preparation can reduce CIT in SPK.
Keywords: Organ Procurement
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






